Covid-19 Infection and the Host Genetic Predisposition: Does it Exist?

COVID‐19 and Renin‐Angiotensin system inhibition – role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?

(2020) Aneta Aleksova et al.   JOURNAL OF INTERNAL MEDICINE

Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill

(2019) Laurent Bitker et al.   CRITICAL CARE CLINICS

The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients

(2019) Denise S. Pinheiro et al.   PLoS One

ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus

(2018) Cheng Liu et al.   Cardiovascular Diabetology

Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China

(2018) Yizhi Pan et al.   Lipids in Health and Disease

ACE2 gene polymorphisms and invasively measured central pulse pressure in cardiac patients indicated for coronarography

(2012) Anna Vašků et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes

(2011) S. K. Patel et al.   AMERICAN JOURNAL OF HYPERTENSION

Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis

(2011) Xiao Li et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Association of Genetic Variants in the Apelin-APJ System and ACE2 With Blood Pressure Responses to Potassium Supplementation: The GenSalt Study

(2010) Q. Zhao et al.   AMERICAN JOURNAL OF HYPERTENSION

Effects of ACE2 Inhibition in the Post-Myocardial Infarction Heart

(2010) Myung-A. Kim et al.   JOURNAL OF CARDIAC FAILURE

Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters

(2010) Keiji Kuba et al.   PHARMACOLOGY & THERAPEUTICS